Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 59, Issue 4, 2000, Pages 308-310

  Redlich, Kurt ^a   Woloszczuk, Wolfgang ^d   Smolen, Josef S ^a   Pietschmann, Peter ^b   Ziegler, Sophie ^a   Kiener, Hans P ^a   Spitzauer, Susanne ^c   Stohlawetz, Petra ^a   Bernecker, Peter ^a   Kainberger, Franz ^e   Grampp, Stephan ^e   Kudlacek, Stefan ^f  

^a UNIVERSITY OF VIENNA   (Austria)

^b Division of Rheumatology and Institute of General and Experimental Pathology   (Austria)

^c Institute of Medical Chemistry and Laboratory Diagnostics   (Austria)

^d LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^e Department of Radiology   (Austria)

^f KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CALCIFEDIOL; CALCIUM; COLLAGEN TYPE 1; CREATININE; DEOXYPYRIDINOLINE; ESTRADIOL; FOLLITROPIN; GLUCOCORTICOID; LUTEINIZING HORMONE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS; PROCOLLAGEN; PROGESTERONE; TESTOSTERONE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; HUMAN; LUMBAR SPINE; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PHOSPHATE BLOOD LEVEL; PREMENOPAUSE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; FEMALE; FEMUR; HUMANS; LUMBAR VERTEBRAE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; OSTEOPOROSIS; PREMENOPAUSE;

EID: 0034030547     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.4.308     Document Type: Article

References (15)

1. 1 Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646-50.
2. 2 Kalla AA, Meyers OL, Parkyn ND, Kotze TJ. Osteoporosis screening-radiogrammetry revisited. Br J Rheumatol 1989; 28:511-17.
3. 3 Dhillon VB, Davies MC, Hall ML, Round JM, Ell PJ, Jacobs HS, et al. Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometry. Ann Rheum Dis 1990;49:624-6.
4. 4 Kalla AA, Fataar AB, Jessop SJ, Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993;36:1726-34.
5. 5 Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
6. 6 Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992;10:541-7.
7. 7 Smolen JS. Clinical and serological features of SLE. In: Smolen JS, Zielinsky CC. Systemic lupus erythematosus. Berlin: Springer-Verlag, 1987.
8. 8 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;843:1-129.
9. 9 Li EK, Tam LS, Young RP, Ko GTC, Li M, Lau EMC. Loss of bone mineral density in chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids. Br J Rheumatol 1998;37:405-10.
10. 10 Peretz A, Praet JP, Bosson D, Rozenberg S, Bourdoux P. Serum osteocalcin in the assessment of corticosteroid induced osteoporosis. Effect of long and short term corticosteroid treatment. J Rheumatol 1989;16:363-7.
11. 11 Jungers P, Nahoul K, Pelissier C, Dougados M, Tron F, Bach JF. Low plasma androgens in women with active or quiescent systemic lupus erythematosus. Arthritis Rheum 1982;25:454-7.
12. 12 Lahita RG, Bradlow HL, Fishman J, Kunkel HG. Abnormal estrogen and androgen metabolism in the human with systemic lupus erythematosus. Am J Kidney Dis 1982;2:206-11.
13. 13 Kapur SP, Reddi AH. Influence of testosterone and dihydrotestosterone on bone-matrix induced endochondral bone formation. Calcif Tissue Int 1989;44:108-13.
14. 14 Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 1989;69:523-7.
15. 15 Khosla S, Melton LJ, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 1998;83:2266-74.